ANDA 216496, held by Mankind Pharma. Phenylephrine Hydrochloride.
As of Nov 16, 2026, ANDA 216496 (Phenylephrine Hydrochloride), held by Mankind Pharma, was first approved by FDA on Jan 11, 2023, with 0 approved supplements and 0 published complete response letters.
Phenylephrine Hydrochloride Ophthalmic Solution, USP 10%, is indicated to dilate the pupil. Phenylephrine Hydrochloride Ophthalmic Solution is an alpha-1 adrenergic receptor agonist indicated to dilate the pupil
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 11, 2023 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenylephrine Hydrochloride10% · solution/drops;ophthalmic | Phenylephrine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters